Persistence of Mumps Antibodies after 2 Doses of Measles‐Mumps‐Rubella Vaccine | Zendy

Charles W. LeBaron | Zendy; Bagher Forghani | Zendy; Carol L. Beck | Zendy; Cedric Brown | Zendy; Daoling Bi | Zendy; Cynthia Cossen | Zendy; Bradley J. Sullivan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Persistence of Mumps Antibodies after 2 Doses of Measles‐Mumps‐Rubella Vaccine

Author(s) -

Charles W. LeBaron,

Bagher Forghani,

Carol L. Beck,

Cedric Brown,

Daoling Bi,

Cynthia Cossen,

Bradley J. Sullivan

Publication year - 2008

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/596207

Subject(s) - measles , rubella , immunogenicity , mumps vaccine , mmr vaccine , medicine , measles mumps rubella vaccine , rubella vaccine , virology , persistence (discontinuity) , immunology , mumps virus , antibody , vaccination , geotechnical engineering , engineering

Since 1990, most US schoolchildren have received a second dose of measles-mumps-rubella vaccine (MMR2) at kindergarten entry. The objective of the present study was to evaluate the short- and long-term mumps immunogenicity of MMR2.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research